Middle EAST Carcinoid Syndrome Drug Market Intelligence Study:...

adicionou um novo artigo Outro

2026-03-02 11:19:05 -

Middle EAST Carcinoid Syndrome Drug Market Intelligence Study: Current Scenario and Future Potential

The Middle EAST Carcinoid Syndrome Drug Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by several factors, including the rising incidence of carcinoid tumors, increased awareness of carcinoid syndrome among healthcare professionals, and advancements in drug development. The...

0 Comentários 0 Compartilhamentos 350 Visualizações 0 Anterior